Analytical Testing

How to Read a Peptide Certificate of Analysis

A field-by-field guide to peptide COAs, including identity, purity, assay, method details, specifications, signatures, and common warning signs.

TSMS Labs· 12 min· Published Jul 31, 2026

How to Read a Peptide Certificate of Analysis

A Certificate of Analysis, or COA, summarizes test results for a defined batch of material. A useful COA links the sample identity to specifications, methods, numerical results, and authorized review. It is not simply a decorative page containing a purity percentage.

Confirm document identity first

The COA should clearly identify:

  • product or material name
  • sequence or chemical identifier where appropriate
  • lot or batch number
  • manufacturing or test date
  • report or certificate number
  • quantity or presentation
  • manufacturer and testing laboratory
  • revision or supersession status

The batch identifier on the COA must match the batch identifier on the physical material and related records.

Specification, result, and status

A strong COA distinguishes among:

  • Test: the attribute being measured
  • Method: the procedure or controlled method number
  • Specification: the acceptance criterion
  • Result: the measured value
  • Status: pass, fail, conforming, or other disposition

A result without a predefined acceptance criterion is less informative. Likewise, a “Pass” statement without the numerical result may obscure how close the batch was to a limit.

Identity

Peptide identity may be supported by intact-mass spectrometry, LC-MS, amino-acid analysis, peptide mapping, sequencing, or a combination of techniques.

Ask:

  • Does the report show the theoretical mass?
  • Is the observed value stated?
  • Are units and mass type clear?
  • Is the result deconvoluted?
  • Does the test distinguish the target from close analogs?

An intact-mass match is valuable but may not prove complete sequence fidelity or stereochemical correctness.

Chromatographic purity

HPLC or UPLC purity usually reports the relative area of the principal peak. Interpretation requires method context:

  • column type
  • mobile phases
  • gradient
  • detector and wavelength
  • flow rate
  • temperature
  • injection amount
  • integration rules
  • run time
  • system-suitability results

A purity value without a chromatogram and method summary is difficult to independently assess.

Assay and peptide content

Assay is not necessarily the same as HPLC purity. Assay estimates the quantity of target analyte relative to a standard. Net peptide content may correct for water, counterion, and other non-peptide mass.

A complete quantitative picture may include:

  • chromatographic purity
  • assay
  • water content
  • residual solvents
  • counterion content
  • net peptide content

Water content

Lyophilized products can retain residual moisture. Karl Fischer titration is commonly used when specific water measurement is required. Loss on drying is broader and can include other volatile components, so the methods are not interchangeable.

Residual solvents

Residual solvents may originate from synthesis, cleavage, purification, or drying. Gas chromatography is commonly used. The COA should identify which solvents were tested, the units, and the acceptance limits.

Counterions and salts

Peptides purified with acidic mobile-phase additives may be isolated as salts or contain counterions such as trifluoroacetate or acetate. Counterion content contributes to total mass and can influence solubility, pH, and assay interpretation.

Microbiological attributes

Where relevant to the stated specification, a COA may include:

  • bioburden
  • bacterial endotoxin
  • sterility
  • microbial limits

These terms are not interchangeable. A low endotoxin result does not prove sterility, and a sterility test does not quantify endotoxin.

Review the attached raw-data summaries

A defensible COA package may include:

  • representative chromatogram
  • peak table
  • mass spectrum
  • deconvoluted mass result
  • system-suitability data
  • sample preparation
  • method identifier
  • analyst and reviewer signatures

Raw data should be traceable to the same batch and test date.

Common warning signs

Be cautious when a COA has:

  • no lot number
  • no testing laboratory identity
  • no method reference
  • no numerical specifications
  • identical chromatograms reused across batches
  • inconsistent dates
  • mismatched sample names
  • missing units
  • cropped spectra without axes
  • purity claims unsupported by integration tables
  • a mass spectrum presented as proof of purity
  • a “sterile” claim without an applicable test and quality framework

Third-party testing

Third-party testing can improve independence, but the phrase alone is not enough. Confirm the laboratory’s identity, scope, test method, sample chain of custody, and report authenticity.

A third-party laboratory analyzes the sample it receives. It cannot independently guarantee that the sampled vial is representative of all units in a batch unless sampling controls support that conclusion.

Frequently asked questions

Does a COA prove that every vial in a batch is identical?

No. It reports results for the tested sample or composite under a defined sampling plan.

Is 99% HPLC purity equivalent to 99% assay?

No. They are different measurements.

Can a COA be valid without raw data?

A summary certificate can be legitimate, but confidence and auditability improve when traceable raw-data summaries and method information are available.

Does “passes mass spectrometry” prove the sequence?

It supports molecular identity, but additional methods may be needed for sequence-specific or stereochemical assurance.

COA review checklist

Before accepting a COA, verify:

  • batch identity
  • test laboratory
  • methods
  • specifications
  • numerical results
  • units
  • dates
  • signatures
  • chromatogram and spectrum traceability
  • consistency between purity, assay, water, and content claims

Key takeaways

A COA is meaningful when it connects a specific batch to suitable methods, explicit specifications, traceable data, and authorized review. The most important question is not “Does it say 99%?” but “What exactly was measured, how was it measured, and what claim does that result support?”

References

  1. FDA. Analytical Procedures and Methods Validation for Drugs and Biologics: Guidance for Industry.
  2. ICH M10. Bioanalytical Method Validation and Study Sample Analysis.

TSMS Labs educational disclaimer: For laboratory research and educational purposes only. Not for human consumption. This content is not medical, clinical, or regulatory advice.